References
- Akiyama Y, Nagahara N, Kashihara T, et al. (1995). In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly(acrylic acid) derivative. Pharm Res 12:397–405
- Arafa HM, Sayed-Ahmed MM. (2003). Protective role of carnitine esters against alcohol-induced gastric lesions in rats. Pharmacol Res 48:285–90
- Arora S, Ali J, Ahuja A, et al. (2005). Floating drug delivery systems: a review. AAPS PharmSciTech 19:E372–90
- Deshpande AA, Shah NH, Rhodes CT, Malick W. (1997). Development of a novel controlled-release system for gastric retention. Pharm Res 14:815–19
- Fix JA, Cargill R, Engle K. (1993). Controlled gastric emptying, Part 3. Gastric residence time of a nondisintregrating geometric shape in human volunteers. Pharm Res 10:1087–9
- Gröning R, Berntgen M, Georgarakis M. (1998). Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit. Eur J Pharm Biopharm 46:285–91
- Halliwell B, Gutteridge A. (1987). Free radicals in biology and medicine. Oxford: Clarendon Press. 247 p
- Hwang SJ, Park H, Park K. (1998). Gastric retentive drug delivery systems. Crit Rev Ther Drug Carrier Syst 15:243–84
- Kawashima Y, Niwa T, Takeuchi H, et al. (1991). Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J Contr Rel 16:279–89
- Kawashima Y, Niwa T, Takeuchi H, et al. (1992). Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 81:135–40
- Lee JH, Park TG, Choi HK. (1999). Development of oral drug delivery system using floating microspheres. J Microencapsul 16:715–29
- Moës AJ. (1993). Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 10:143–95
- Ojha G, Tanwar YS, Chauhan CS, Naruka PS. Floating microspheres: development, characterization and application. pharmaceutical information for you, May 2006. Available at: www.pharmainfo.net/.../floating-microspheres-development-characterization-and-applications-United States [last accessed 14 July 2008]
- Park K. (1988). Enzyme-digestible swelling hydrogels as platforms for long-term oral drug delivery: synthesis and characterization. Biomaterials 9:435–41
- Rajinikanth PS, Mishra B. (2007). Preparation and in vitro characterization of gellan based floating beads of acetohydroxamic acid for eradication of H. pylori. Acta Pharm 57:413–27
- Reddy BP, Dorle AK, Krishna DK. (1990). Albumin microspheres: effect of process variables on the distribution and in vitro release. Drug Dev Ind Pharm 16:1781–803
- Rouge N, Cole ET, Doelker E, Buri P. (1998). Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs. Pharm Dev Technol 3:73–84
- Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. (2003). Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 55:297–304
- Soll AH. (1990). Pathogenesis of peptic ulcers and implication for therapy. New Eng J Med 322:909–16
- Streubel A, Siepmann J, Bodmeier R. (2006). Gastroretentive drug delivery system. Expert Opin Drug Deliv 3:217–33
- Surendra S. (1999). Evaluation of gastric antiulcer activity of fixed oil of tulsi and possible mechanism. Ind J Exp Biol 36:253–57
- Tayade PT, Kale RD. (2007). A multiple unit floating drug delivery system of Piroxicam using Eudragit polymer. Ind J Pharm Sci 69:120–3
- Yuasa H, Takashima Y, Kanaya Y. (1996). Studies on the development of intragastric floating and sustained release preparation. I. Application of calcium silicate as a floating carrier. Chem Pharm Bull 44:1361–6